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In our welcome editorial to launch Fungal Biology and 
Biotechnology in October 2014 we stated that ‘This is a 
new golden age of discovery in the fungi, and an excit-
ing time to take part of this adventure’ [1]. At that time 
we made a number of promises and predictions (Box 1). 
Now, two years after the birth of the first open-access 
journal devoted to fungal bio(techno)logy it is time to 
take stock of what has been achieved and what further 
progress needs to be made on making the vision and 
promise for this exciting journal to come true. 
Let’s look at the facts: 26 peer-reviewed articles have 
been published from 51 manuscripts submitted to 
FBBiotech within the last two years. This selectivity 
reflects a strong basis to publish articles that are scien-
tifically valid and feature new directions, and also on our 
wish to publish articles that are of interest to the fungal 
research community. These articles have the potential 
to shape future directions within the sciences of fungal 
bio(techno)logy—because they open up new avenues, 
represent considerable scientific or technological break-
throughs and/or ‘think’ outside the box. Indeed, the 
articles published by FBBiotech have become a success 
story: in total, more than 62,000 article accesses can be 
counted with an average of 2600 accesses per article (as 
of September 22nd, 2016), which compares favorably 
with other fungal articles published in well-established 
BMC journals in the field of applied microbiology from 
the same period (October 2014–September 2016) such 
as Microbial Cell Factories (1000 accesses/article), BMC 
Microbiology (1400 accesses/article) and Biotechnology 
for Biofuels (2200 accesses/article). The 2016 citations 
to papers published in 2014 and 2015, and with still a 
quarter of the year to go, already account for a current 
unofficial minimum journal impact factor (JIF) of 2.7, as 
identified through Google Scholar and Springer, and then 
each citation validated manually. We will be in contact 
with Thomson Reuters about being tracked for an official 
JIF, which is currently projected to be above 3, if calcu-
lated also for the citations for the 2016 papers. We thank 
the members of the editorial board [2], reviewers and 
authors for their support of this new journal. Without an 
investment by the research community, this level of suc-
cess would not have been possible.
The majority of first or main authors of FBBiotech 
papers come from Germany (32  %), the US (14  %), The 
Netherlands (13  %) and UK (11  %) and the majority of 
readers come from the US (28 %), India (20 %), Germany 
(17  %), China and UK (each 10  %), thus from countries 
with strong fungal scientific communities and/or from 
countries with considerable public funding and private 
investment in the field of fungal biotechnology.
The open-access philosophy of FBBiotech generates 
high ‘scores’ for FBBiotech articles when alternative 
metric methods are evaluated as well. These methods, 
such as Altmetric [3], measure not only downloads and 
the citation frequency but also the attention surround-
ing an article. The most recent FBBiotech publications 
have especially generated a huge interest in the scien-
tific and public community, e.g. with Altmetric scores of 
7–11 putting them into the top 25 % of all research out-
puts scored by Altmetric. Manuscripts expected to be of 
high relevance to the fungal research community indeed 
became the most read, cited and discussed papers, and 
thus the most influential and in cases most inspirational 
ones. The three most read are Claudio Scazzocchio’s 
opening review that discusses his views on how fungal 
biology has changed during his career and particular in 
the post-genomic era [4], the Richter et al. research arti-
cle on the new use of Aspergillus niger as a highly efficient 
production platform for secondary metabolites [5], and 
the research article of Matsu-ura et al. demonstrating the 
successful establishment of the CRISPR-Cas technology 
for genome editing purposes in Neurospora crassa [6].
Beyond the conventional article, FBBiotech aimed to 
address other aspects of how fungi impact society. Two 
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the social responsibilities as scientists to talk more about 
our research on microorganisms as well as the need for 
new technologies to enable the microorganisms them-
selves to do their own ‘talking’ [7]. Second, the results of 
the first European academic-industry Think Tank meet-
ing held ever in the history of fungal science was just 
published as a White Paper in FBBiotech [8]. This timely 
and foreword looking paper discusses research opportu-
nities and challenges in fungal biology and biotechnol-
ogy for the coming decade and defines the roadmap on 
how better to exploit industrially-used fungi and more 
efficiently fight pathogenic fungi, and thus make us fun-
gal scientists significantly contribute to the world-wide 
manifold efforts essential to secure human welfare in the 
twenty-first century.
Using the online format of the journal also opens other 
opportunities to promote fungal biology more widely. 
FBBiotech has sponsored poster prizes at the differ-
ent fungal conferences, including the European Fungal 
Genetics Conference held this year in Paris (ECFG13). 
Three posters of young scientists were selected in three 
sessions as being highlights, and the authors then inter-
viewed about their work and visions, with this informa-
tion posted on the BioMed Central blog and linked to the 
FBBiotech homepage. The journal will again feature at the 
29th Fungal Genetics Conference at Asilomar Confer-
ence Center in March 2017.
Taken together, the journal FBBiotech has established 
itself—although still in its infancy—as an important 
platform to communicate key findings within the scien-
tific community. The journal also provides an important 
multiplying factor by offering scientists the opportunity 
to communicate their findings across sectors as well as to 
the public, and by this generating considerable interest 
for their own work in a broader framework.
Our opening editorial also touched on concerns in the 
publishing world that had become evident, particularly 
the rise of predatory journals. A new issue is at the other 
extreme, with how the reputation of well-established 
journals is being misused to infer the value of scientific 
contributions by individual researchers. Recent initiatives 
explore ways out of the “preoccupation of many scientists 
with publishing their work in a journal with the highest 
impact factor […] with given clinical names such as ‘jour-
nal mania’, ‘IF mania’ and ‘impactitis” [9]. The American 
Society for Microbiology has thus decided this year to 
remove journal impact factor information from all ASM 
journal websites (see e.g. [10]). We congratulate the edi-
tors of these journals for their stand to fight against the 
inappropriate focus on JIFs and their recent misuse for 
publication, funding, hiring, and even promotion deci-
sions [11–13]. As authors and editors we have the free-
dom to choose where we want to see our work published 
and which journals we consider as the most appropriate 
ones for communicating our research data, opinions and 
visions to our community. We are convinced that this 
decision should only be based on high-quality science, 
rigorous peer-reviewing by academic experts, a fast-
handling process and—last but not least—an open-access 
policy. All of this is ensured by FBBiotech. We thus hope 
to handle your submissions soon!
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Box 1 Statement from opening editorial
We intend for the journal to become a hub for researchers seeking 
information on their favorite topics as well as considering new or 
alternative directions. The journal shall become a platform for scien‑
tists from academia and industry to present their hottest findings in 
unicellular or multicellular fungal systems, in medical or industrial 
strains, and in so far unexplored species. This will be a platform for 
experts to discuss their visions on how fungi can help us to address 
some of the key challenges of the twenty‑first century [1]
